Evidence · idea-022

PMID (PubMed identifier) 12941724 (Armstrong DG, Lavery LA, Kimbriel HR, Nixon BP, Boulton AJM, "Activity patterns of patients with diabetic foot ulceration: patients with active ulceration may not adhere to a standard pressure off-loading regimen," Diabetes Care 2003;26(9):2595-7) reports that 20 patients with neuropathic diabetic foot wounds, off-loaded with a removable cast walker, wore it for an average of about 28% of their total daily steps.

PMID 15735186 ("Evaluation of removable and irremovable cast walkers in the healing of diabetic foot wounds: a randomized controlled trial," Diabetes Care 2005;28(3):551) randomized 50 patients with University of Texas grade 1A diabetic foot ulcers to a removable cast walker or the same walker wrapped in cohesive bandage so it could not easily be removed, and reported a higher proportion healed at 12 weeks in the irremovable group (the Generator saw 82.6% versus 51.9% in a secondary summary).

PMID 37226568 (Bus SA, et al., "Guidelines on offloading foot ulcers in persons with diabetes (IWGDF 2023 update)," Diabetes Metab Res Rev 2024;40(3):e3647) recommends a non-removable knee-high offloading device as the first-choice offloading intervention for healing a neuropathic plantar forefoot or midfoot ulcer in a person with diabetes, with a removable knee-high or ankle-high device as second choice where non-removable offloading is contraindicated or not tolerated.

HCPCS (Healthcare Common Procedure Coding System) Level II code L4361 (a HCPCS code for a brace, prosthetic or orthotic) describes a walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated, off-the-shelf; L4360 describes the same item prefabricated and customized to fit by an individual with expertise.

The DME MAC (durable medical equipment Medicare administrative contractor) policy article for ankle-foot and knee-ankle-foot orthoses (article A52457, companion to LCD (local coverage determination) L33686 (a Medicare local coverage determination number)) instructs that walking boots otherwise coded L4360, L4361, L4386, L4387 or L4631 must be coded A9283 (a HCPCS code for a supply) when used solely for the prevention or treatment of a lower-extremity ulcer or pressure.

HCPCS A9283 describes a foot pressure off-loading or supportive device and is a non-covered item under Medicare, so a walker coded A9283 carries no Medicare DME (durable medical equipment) payment.

CPT (Current Procedural Terminology) 29445 describes application of a rigid total contact leg cast and is payable under the Medicare Physician Fee Schedule; a secondary source reported a 2021 non-facility payment of about $102 and an OPPS assignment to APC 5102.

Open coding question, not a fact: whether applying a rigid walker locked onto the leg with a clinician-released closure may be reported as "application of rigid total contact leg cast" under CPT 29445 is not established; the Generator found no AMA, CMS or MAC (Medicare administrative contractor) statement either way. If it may not, this candidate has no identified payment route in its indication.

TCC-EZ is a total contact cast system marketed by Integra LifeSciences (originally Derma Sciences, available since about 2008) whose manufacturer coding and reimbursement guide identifies CPT 29445 as the primary code for its application.

HCPCS Q-codes exist for casting supplies used in physician offices (the Generator believes Q4037 and Q4038 describe short leg cast supplies for adults in plaster and fiberglass respectively); whether any such code could apply to a non-plaster, non-fiberglass locked walker kit is unknown.

Under National Correct Coding Initiative policy as summarized by a coding vendor, casting or strapping at the same anatomic site during the same encounter as a restorative procedure is not separately reportable without a distinct-service modifier, which bears on a weekly visit that combines ulcer debridement with reapplication of the offloading device.

21 CFR (Title 21 of the Code of Federal Regulations) 890.3475 classifies a limb orthosis as a Class I device exempt from premarket notification.

21 CFR 888.5940 classifies a cast component; the Generator believes it is Class I and has not confirmed its class, exemption status, or whether FDA (US Food and Drug Administration) would read a locked walker assembly into it rather than into 890.3475.

Reasoning, not a fact: labeling this device with an explicit claim to improve or accelerate diabetic foot ulcer healing would move it outside a Class I orthosis or cast component reading and toward a De Novo (De Novo classification request) supported by clinical outcome data.

TAM (total addressable market) component 1 of 4, incidence: AHRQ Data Points #2 (PMID 22049565) reports an annual diabetic foot ulcer incidence of about 6.0% among Medicare fee-for-service (Parts A and B) beneficiaries with diabetes, 2006-2008.

TAM component 2 of 4, prevalence: AHRQ Data Points #1 (PMID 22049561) reports a yearly diabetic foot ulcer prevalence of about 8% among Medicare fee-for-service beneficiaries with diabetes, 2006-2008, and roughly 19% in the subgroup with peripheral arterial disease.

TAM volume anchor: annual Medicare Part B (Medicare Part B) utilization of CPT 29445 is published in CMS physician/supplier procedure utilization data and is the checkable volume floor for the procedure this kit would be used in; the Generator extracted no figure and asserts none.

TAM component 3 of 4, price per unit: no kit price is asserted. The Generator's design intent is that the per-application closure set, plus an amortized share of the walker shell, fits within the supply portion of the non-facility payment for CPT 29445; that portion was not looked up.

TAM component 4 of 4, addressable share: the fraction of diabetic foot ulcers that are neuropathic, plantar, forefoot or midfoot, and free of infection, osteomyelitis and critical ischemia is not known to the Generator; no figure is asserted.

FTO (freedom to operate), named families: US patents 8,043,245 and 8,454,546, each titled "Orthopedic device having a patient compliance system," were identified by web search, and Google Patents lists the assignee of US8043245B2 as Össur hf. The Generator did not determine their claims, legal status or expiry, or whether any claim reads on a mechanically locked closure with no electronic compliance monitoring.

FTO, field coverage: beyond the two numbers in the preceding claim, no patent search was performed; the FTO field for locking, keyed or tamper-evident orthosis and walker closures, non-removable offloading devices, and frangible emergency-release straps is unexamined.

Assumption, not a fact: wound-care and podiatry clinicians who do not routinely apply total contact casts would adopt a locked walker as their non-removable offloading option, because it is faster to apply and remove and needs no casting skill.

Assumption, not a fact: patients offered a walker they cannot remove at home would accept it at rates similar to or better than a total contact cast, and would use the emergency release only in emergencies rather than as a routine way to take the device off.

Mechanism and clinical-risk reasoning (Generator's own, flagged as reasoning rather than finding): a non-removable device hides the foot for a week, so the named failure modes are device-induced pressure injury or new ulceration in an insensate limb, unrecognized infection progression between visits, falls from a rocker-soled walker, skin maceration, closure failure or deliberate tampering, and misuse in patients with ischemia or infection whom the intended use excludes. None has been characterized for this device because it does not exist.

No device of this candidate's design exists as a prototype, and no bench or clinical data exist for it; every property attributed to it in this file is design intent.

Competitive position: knee-high offloading walkers are commodity products sold by several large orthopedic companies, and TCC-EZ occupies the kit-based total contact cast niche; the Generator identified no marketed walker with a clinician-released lock, which is a web-search absence and not evidence of an empty field.

Assumption, not a fact: patients with active plantar diabetic foot ulcers in US wound clinics are typically seen about weekly for debridement and wound assessment, so a weekly reapplication fits an existing visit rather than adding one.

Neither open macro-trend seed was relied on: this device is Class I and non-powered, has no Breakthrough case, and contains no machine-learning function.

No domain dossier exists in this repo for diabetic foot ulcer offloading: the knowledge-base/domains directory as of 2026-09-28 holds README.md, _template.md and twelve dossiers on other clinical areas.